FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023997066> ?p ?o ?g. }

• W2023997066 endingPage "468" @default.
• W2023997066 startingPage "458" @default.
• W2023997066 abstract "Study Objective. To determine whether use of nonselective nonsteroidal antiinflammatory drugs (NSAIDs) or cyclooxygenase-2 (COX-2)-selective inhibitors in patients with coronary stents increased the 3–year rate of major adverse cardiovascular events (MACE). Design. Population-based cohort study. Data Sources. The Danish National Patient Registry, the Western Denmark Heart Registry, the Danish Nationwide Prescription Database, the Danish Civil Registration System, and the National Registry of Causes of Deaths. Patients. A total of 13,001 patients who underwent first-ever percutaneous coronary intervention with stent implantation between January 1, 2002, and June 30, 2005. Measurements and Main Results. All patients were followed for 3 years after stent implantation for MACE, defined as the first occurrence of myocardial infarction, stent thrombosis, target-lesion revascularization, or cardiac death. Patients' comorbidities were identified from the hospital registries; time-varying use of NSAIDs and concomitant drugs was determined from the Danish Nationwide Prescription Database. For each clinical outcome (MACE), the 3–year risk was computed. We used Cox proportional-hazards regression analysis to compute hazard ratios (HRs) as a measure of relative risk, controlling for potential confounders. During the follow-up period, 5407 patients (41.6%) redeemed at least one NSAID prescription. There were 686 hospitalizations for myocardial infarction (5.3% of patients), 146 for stent thrombosis (1.1%), and 1091 for target-lesion revascularization (8.4%). A total of 1220 patients (9.4%) died during the follow-up period; 637 (4.9%) died of cardiac causes. Compared with no NSAID use, the adjusted HR for MACE was 1.04 (95% confidence interval [CI] 0.83–1.31) for nonselective NSAID use and 1.00 (95% CI 0.81–1.25) for COX-2 inhibitor use. Conclusion. Use of nonselective NSAIDs or COX-2 inhibitors was not associated with an increased rate of MACE in patients with coronary stents. However, we cannot rule out small risks associated with individual NSAIDs." @default.
• W2023997066 created "2016-06-24" @default.
• W2023997066 creator A5002757728 @default.
• W2023997066 creator A5013878625 @default.
• W2023997066 creator A5028677643 @default.
• W2023997066 creator A5033040903 @default.
• W2023997066 creator A5039413618 @default.
• W2023997066 creator A5050587534 @default.
• W2023997066 creator A5067129696 @default.
• W2023997066 date "2011-05-01" @default.
• W2023997066 modified "2023-09-26" @default.
• W2023997066 title "Nonsteroidal Antiinflammatory Drug Use and Cardiovascular Risks After Coronary Stent Implantation" @default.
• W2023997066 cites W1511423923 @default.
• W2023997066 cites W1780627874 @default.
• W2023997066 cites W1965515665 @default.
• W2023997066 cites W1973071076 @default.
• W2023997066 cites W2000445173 @default.
• W2023997066 cites W2011941025 @default.
• W2023997066 cites W2012920835 @default.
• W2023997066 cites W2016592209 @default.
• W2023997066 cites W2019370793 @default.
• W2023997066 cites W2022550378 @default.
• W2023997066 cites W2023022714 @default.
• W2023997066 cites W2027116427 @default.
• W2023997066 cites W2038932922 @default.
• W2023997066 cites W2049120615 @default.
• W2023997066 cites W2055394727 @default.
• W2023997066 cites W2066501580 @default.
• W2023997066 cites W2067621583 @default.
• W2023997066 cites W2087150869 @default.
• W2023997066 cites W2087815860 @default.
• W2023997066 cites W2100631748 @default.
• W2023997066 cites W2121972315 @default.
• W2023997066 cites W2129168200 @default.
• W2023997066 cites W2134617241 @default.
• W2023997066 cites W2134987486 @default.
• W2023997066 cites W2139776244 @default.
• W2023997066 cites W2140452679 @default.
• W2023997066 cites W2141165366 @default.
• W2023997066 cites W2147174959 @default.
• W2023997066 cites W2158131645 @default.
• W2023997066 cites W2158968701 @default.
• W2023997066 cites W2164595809 @default.
• W2023997066 cites W2546495710 @default.
• W2023997066 doi "https://doi.org/10.1592/phco.31.5.458" @default.
• W2023997066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21923427" @default.
• W2023997066 hasPublicationYear "2011" @default.
• W2023997066 type Work @default.
• W2023997066 sameAs 2023997066 @default.
• W2023997066 citedByCount "8" @default.
• W2023997066 countsByYear W20239970662013 @default.
• W2023997066 countsByYear W20239970662014 @default.
• W2023997066 countsByYear W20239970662016 @default.
• W2023997066 countsByYear W20239970662017 @default.
• W2023997066 countsByYear W20239970662018 @default.
• W2023997066 countsByYear W20239970662019 @default.
• W2023997066 crossrefType "journal-article" @default.
• W2023997066 hasAuthorship W2023997066A5002757728 @default.
• W2023997066 hasAuthorship W2023997066A5013878625 @default.
• W2023997066 hasAuthorship W2023997066A5028677643 @default.
• W2023997066 hasAuthorship W2023997066A5033040903 @default.
• W2023997066 hasAuthorship W2023997066A5039413618 @default.
• W2023997066 hasAuthorship W2023997066A5050587534 @default.
• W2023997066 hasAuthorship W2023997066A5067129696 @default.
• W2023997066 hasConcept C126322002 @default.
• W2023997066 hasConcept C141071460 @default.
• W2023997066 hasConcept C164705383 @default.
• W2023997066 hasConcept C207103383 @default.
• W2023997066 hasConcept C2777546689 @default.
• W2023997066 hasConcept C2778283817 @default.
• W2023997066 hasConcept C2778583881 @default.
• W2023997066 hasConcept C2780400711 @default.
• W2023997066 hasConcept C2780739214 @default.
• W2023997066 hasConcept C2780911114 @default.
• W2023997066 hasConcept C2908647359 @default.
• W2023997066 hasConcept C44249647 @default.
• W2023997066 hasConcept C500558357 @default.
• W2023997066 hasConcept C50382708 @default.
• W2023997066 hasConcept C71924100 @default.
• W2023997066 hasConcept C99454951 @default.
• W2023997066 hasConceptScore W2023997066C126322002 @default.
• W2023997066 hasConceptScore W2023997066C141071460 @default.
• W2023997066 hasConceptScore W2023997066C164705383 @default.
• W2023997066 hasConceptScore W2023997066C207103383 @default.
• W2023997066 hasConceptScore W2023997066C2777546689 @default.
• W2023997066 hasConceptScore W2023997066C2778283817 @default.
• W2023997066 hasConceptScore W2023997066C2778583881 @default.
• W2023997066 hasConceptScore W2023997066C2780400711 @default.
• W2023997066 hasConceptScore W2023997066C2780739214 @default.
• W2023997066 hasConceptScore W2023997066C2780911114 @default.
• W2023997066 hasConceptScore W2023997066C2908647359 @default.
• W2023997066 hasConceptScore W2023997066C44249647 @default.
• W2023997066 hasConceptScore W2023997066C500558357 @default.
• W2023997066 hasConceptScore W2023997066C50382708 @default.
• W2023997066 hasConceptScore W2023997066C71924100 @default.
• W2023997066 hasConceptScore W2023997066C99454951 @default.
• W2023997066 hasIssue "5" @default.
• W2023997066 hasLocation W20239970661 @default.

• next